# Cardiac Biomarkers and Troponin > Cardiac biomarkers and troponin for NEET-PG Medicine cover troponin kinetics, CK-MB and myoglobin, non-ischaemic troponin rises and detecting reinfarction. - Canonical URL: https://prepelephant.com/topics/neet-pg/medicine/cardiac-biomarkers-and-troponin - Exam / course: NEET-PG · Subject: Medicine - Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team - First published: 2026-10-08 - Last updated: 2026-10-08 - Reference basis: Harrison's Principles of Internal Medicine; Fourth Universal Definition of Myocardial Infarction; Tietz Textbook of Clinical Chemistry and Molecular Diagnostics - How to cite: "Cardiac Biomarkers and Troponin", PrepElephant, https://prepelephant.com/topics/neet-pg/medicine/cardiac-biomarkers-and-troponin ## Direct answer Cardiac troponin I and T are the preferred biomarkers of myocardial necrosis because their cardiac-specific isoforms stay raised for days after infarction. A rise and fall above the 99th percentile upper reference limit, together with a clinical picture of ischaemia, diagnoses myocardial infarction, while CK-MB and myoglobin now serve mainly as secondary markers. ## What you must remember - **Troponin kinetics:** rises three to four hours after onset, peaks around 12 to 24 hours and stays elevated for about five to fourteen days depending on the isoform, which makes it useful for late presenters. - **CK-MB:** rises four to six hours after onset, peaks at 12 to 24 hours and normalises within 48 to 72 hours, so its early return made it the classical marker for reinfarction. - **Myoglobin:** the earliest marker, rising within one to four hours and normalising within 24 hours, but it is not cardiac-specific and is rarely used alone. - **Threshold:** the 99th percentile upper reference limit defines infarction on high-sensitivity assays, and serial sampling over one to three hours resolves equivocal first values. - **Non-ischaemic rises:** chronic kidney disease, heart failure, pulmonary embolism, myocarditis, sepsis, tachyarrhythmias, cardioversion and strenuous exercise can all raise troponin without plaque rupture. - **Type 2 infarction:** supply-demand mismatch from severe anaemia, hypotension or tachyarrhythmia raises troponin without a culprit plaque, and the universal definition separates it from type 1. - **Reinfarction:** troponin remains high for days to weeks and cannot separate recurrence from residual injury, so a second CK-MB rise after normalisation, with new symptoms or ECG change, is the classical clue. ## Interpreting troponin in three patients Three patients illustrate the reasoning. A 70-year-old man with advanced chronic kidney disease has a raised troponin T at presentation that is essentially unchanged on repeat sampling, no chest pain, and an ECG showing left ventricular hypertrophy without dynamic ST change. This is a chronic non-ischaemic elevation, and the flat trend matters more than the single value. A 58-year-old woman with exertional pain, dynamic ST depression and a troponin that climbs steeply over six hours has acute myocardial infarction, most likely NSTEMI, and the rising trend is what defines it. A third patient with pneumonia and high fever has a troponin rise but no chest pain and no ischaemic ECG change. Sepsis-related myocardial injury is the likely cause, with type 2 infarction considered if hypoxia or hypotension is present. The pattern shows that the reference limit is a threshold for the test, while diagnosis rests on the trend, the symptoms and the ECG. Repeat sampling is the standard response to an equivocal first value, because a single sample is not diagnostic in either direction. ## Where the exam tries to catch you Examiners exploit the difference between cardiac-specific and non-specific markers. Offering total CK as the test of choice for myocardial infarction is a trap, because total CK rises in skeletal muscle injury, including rhabdomyolysis and after intramuscular injections, whereas troponin does not. Myoglobin is the earliest marker, and a candidate who chooses it for early diagnosis must also recognise its poor specificity. LDH peaks late, several days after infarction, which made it useful historically for late presenters but not for modern diagnosis. The everyday trap in Indian wards is the patient with chronic kidney disease who has a raised troponin and is wrongly labelled as having an acute infarct, leading to unnecessary angiography and bleeding risk. The correct response is to read the trend. A final viva angle is that a single troponin is never diagnostic on its own, whichever assay is used. ## Frequently asked questions ### Which cardiac biomarker rises earliest after myocardial infarction? Myoglobin rises earliest, within one to four hours, but it is not cardiac-specific. Cardiac troponin follows at three to four hours and is the preferred marker for diagnosis because of its specificity. ### How long does troponin stay raised after an acute myocardial infarction? Troponin stays elevated for about five to fourteen days, depending on the isoform, with troponin T generally lasting longer than troponin I. A raised value late in presentation may therefore still reflect an infarct that occurred days earlier. ### Why is CK-MB useful for detecting reinfarction? CK-MB normalises within 48 to 72 hours, so a second rise after it has returned to baseline indicates new myocardial injury. Troponin remains elevated for longer, which makes it unreliable for distinguishing early reinfarction from residual injury. ### Can troponin rise without a coronary occlusion? Yes, troponin can rise in chronic kidney disease, heart failure, pulmonary embolism, myocarditis, sepsis and tachyarrhythmia through non-ischaemic myocardial injury or supply-demand mismatch. The clinical context, the trend and the ECG distinguish these from acute plaque-rupture infarction.